Cargando…

Level of evidence for promising subgroup findings in a negative trial

Detalles Bibliográficos
Autores principales:	Tanniou, Julien, van der Tweel, Ingeborg, Roes, Kit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3980385/ http://dx.doi.org/10.1186/1745-6215-14-S1-O105

Ejemplares similares

Subgroup analyses in confirmatory clinical trials: time to be specific about their purposes
por: Tanniou, Julien, et al.
Publicado: (2016)

Sample size calculations in pediatric clinical trials conducted in an ICU: a systematic review
por: Nikolakopoulos, Stavros, et al.
Publicado: (2014)

Risk stratification in clinical trials: a subgroup to be encouraged
por: Clayton, Tim, et al.
Publicado: (2013)

Challenges of defining a non-inferiority margin: a case study of non-inferiority randomized controlled trials of oral anti-thrombolytic agents for prophylaxis of venous thromboembolic events after orthopedic surgery
por: Wangge, Grace, et al.
Publicado: (2011)

An Application of Sequential Meta-Analysis to Gene Expression Studies
por: Novianti, Putri W, et al.
Publicado: (2015)

S120: RANDOMIZED CONTROLLED TRIAL OF THE EFFICACY AND SAFETY OF DEFERIPRONE: SUBGROUP ANALYSIS OF PEDIATRIC PATIENTS IN IRON-OVERLOADED PATIENTS WITH SICKLE CELL DISEASE AND OTHER ANEMIAS
por: Inusa, B, et al.
Publicado: (2022)

Colchicine trial in PFAPA Syndrome and MEFV-negative patients
por: Kadhim, C, et al.
Publicado: (2015)

Efficacy of high-dose alkylating chemotherapy in the adjuvant treatment of HER2/neu-negative primary breast cancer: update of the Dutch randomized trial
por: Rodenhuis, S, et al.
Publicado: (2005)

14th Annual University of Pennsylvania Conference on statistical issues in clinical trials/subgroup analysis in clinical trials: Opportunities and challenges (morning panel discussion)
por: Roes, Kit, et al.
Publicado: (2023)

Accurate quantification of heart valve regurgitation in all four heart valves simultaneously using 3D velocity-encoded MRI with retrospective valve tracking
por: Westenberg, Jos JM, et al.
Publicado: (2009)

Achieving the promise of universal coverage – the role for strategic purchasing
por: Hanson, Kara
Publicado: (2014)

Evidence synthesis in trial design: an example from the neurosciences
por: Egan, Kieren, et al.
Publicado: (2013)

Mandated community treatment: a promising concept for world psychiatry?
por: Monahan, John
Publicado: (2007)

Bacterial anticancer weapons: a promising tool to fight cancer
por: Chakrabarty, Ananda M
Publicado: (2010)

O044 PROMISing questionnaires to measure sleep disturbance and impairment
por: Antonov, A, et al.
Publicado: (2021)

Evidence base for patient and public involvement in clinical trials (EPIC)
por: Gamble, Carrol, et al.
Publicado: (2013)

Making best use of existing evidence when planning trials
por: Roloff, Verena, et al.
Publicado: (2011)

OA09.01. Massage therapy for osteoarthritis of the knee: a randomized dose-finding trial
por: Perlman, A, et al.
Publicado: (2012)

Approaches to participant recruitment and predictors of retention in a large community based public health trial: findings from the building blocks trial
por: Owen-Jones, Eleri, et al.
Publicado: (2013)

48. TOPICAL CAPTOPRIL: A PROMISING THERAPEUTIC AVENUE FOR LYMPHEDEMA TREATMENT
por: Brown, Stav, et al.
Publicado: (2022)

Randomised trial reports continue to be islands of evidence, with few continents in sight
por: Clarke, Michael, et al.
Publicado: (2013)

DESIGN OF THE MYECHILD TRIAL, AN INTERNATIONAL RANDOMISED PHASE III CLINICAL TRIAL IN CHILDREN WITH ACUTE MYELOID LEUKAEMIA INCORPORATING AN EMBEDDED DOSE FINDING STUDY
por: Houlton, Aimee, et al.
Publicado: (2015)

Virological findings from the SARA trial: boosted PI monotherapy as maintenance second-line ART in Africa
por: Pillay, D, et al.
Publicado: (2010)

Using evidence from observational healthcare data to inform a trial design
por: Hansen, Christian Holm, et al.
Publicado: (2013)

Implementation of adaptive dose-finding designs in two early phase haematological trials: clinical, operational, and methodological challenges
por: Yap, Christina, et al.
Publicado: (2013)

A Bayesian dose-finding procedure applied to a seamless phase I/II trial in rheumatoid arthritis
por: Whitehead, Anne, et al.
Publicado: (2011)

Highly potent, fully recombinant RANTES analogues represent promising new candidate microbicides
por: Hartley, Oliver
Publicado: (2006)

Dose transition pathways: a design, analysis and operational tool for dose-finding trials using model-based designs
por: Yap, Christina, et al.
Publicado: (2015)

The value of evidence synthesis in randomised controlled trial (RCT) design, conduct and analysis: MRC clinical trials unit (CTU) at UCL experience
por: Tierney, Jayne F, et al.
Publicado: (2015)

Placental findings in cord accidents
por: Parast, Mana M
Publicado: (2012)

Phase II investigation of a PARP inhibitor (olaparib) in castration resistant prostate cancer (CRPC) which incorporates the possibility that treatment effect may be restricted to biomarker defined subgroups
por: A’Hern, Roger, et al.
Publicado: (2011)

Low-level viraemia during treatment with darunavir/r monotherapy versus DRV/r + 2NRTIs in the MONET trial
por: Clumeck, N, et al.
Publicado: (2010)

Incidental findings in the oncology patient: ovaries
por: Forstner, Rosemarie
Publicado: (2014)

Incidental findings in the oncology patient: liver
por: Schima, Wolfgang
Publicado: (2014)

P411 Genus specific real-time PCR-a promising technique for rapid diagnosis of fungal keratitis
por: Tawde, Yamini, et al.
Publicado: (2022)

P076 The promising antimycotic activities of a novel cyclic antifungal lipopeptide against Human Dermatophyte Isolates
por: Ramesh, Swetha, et al.
Publicado: (2022)

Molecular classification of triple-negative tumors
por: Prat, A, et al.
Publicado: (2011)

Decreased exercise capacity in ‘asymptomatic’ patients late after relief of severe pulmonary stenosis and moderate restenosis: evidence for diastolic dysfunction
por: Romeih, Soha, et al.
Publicado: (2012)

MULTIPLATFORM MOLECULAR ANALYSIS OF VESTIBULAR SCHWANNOMA REVEALS TWO ROBUST SUBGROUPS WITH DISTINCT MICROENVIRONMENT
por: Landry, Alexander P, et al.
Publicado: (2023)

Finding mechanisms from metabolic signatures of disease
por: Newgard, Christopher B
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_h750mrj2bc7fibooi4vtbm49kp